- Home
- EBON vs PRPO Comparison
EBON vs PRPO Comparison
Compare EBON & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBON
- PRPO
- Stock Information
- Founded
- EBON 2010
- PRPO N/A
- Country
- EBON China
- PRPO United States
- Employees
- EBON N/A
- PRPO N/A
- Industry
- EBON Semiconductors
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- EBON Technology
- PRPO Industrials
- Exchange
- EBON Nasdaq
- PRPO Nasdaq
- Market Cap
- EBON 24.4M
- PRPO 22.0M
- IPO Year
- EBON 2020
- PRPO N/A
- Fundamental
- Price
- EBON $4.95
- PRPO $18.72
- Analyst Decision
- EBON
- PRPO
- Analyst Count
- EBON 0
- PRPO 0
- Target Price
- EBON N/A
- PRPO N/A
- AVG Volume (30 Days)
- EBON 10.5K
- PRPO 16.2K
- Earning Date
- EBON 08-15-2025
- PRPO 11-05-2025
- Dividend Yield
- EBON N/A
- PRPO N/A
- EPS Growth
- EBON N/A
- PRPO N/A
- EPS
- EBON N/A
- PRPO N/A
- Revenue
- EBON $7,337,066.00
- PRPO $21,242,000.00
- Revenue This Year
- EBON N/A
- PRPO N/A
- Revenue Next Year
- EBON N/A
- PRPO N/A
- P/E Ratio
- EBON N/A
- PRPO N/A
- Revenue Growth
- EBON 104.28
- PRPO 27.05
- 52 Week Low
- EBON $3.00
- PRPO $3.90
- 52 Week High
- EBON $10.94
- PRPO $22.38
- Technical
- Relative Strength Index (RSI)
- EBON 69.71
- PRPO 62.80
- Support Level
- EBON $4.01
- PRPO $19.40
- Resistance Level
- EBON $4.20
- PRPO $22.38
- Average True Range (ATR)
- EBON 0.32
- PRPO 1.37
- MACD
- EBON 0.09
- PRPO 0.31
- Stochastic Oscillator
- EBON 92.19
- PRPO 55.02
About EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.